Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: A review

Journal of Psychopharmacology

Volumn 20, Issue 5, 2006, Pages 693-707

  Rasmusson, Ann M ^a,b,c   Picciotto, Marina R ^a   Krishnan Sarin, Suchitra ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA National Center for PTSD   (United States)

^c VA National Center for Posttraumatic Stress Disorder   (United States)

Author keywords

Cortisol; Fear conditioning; HPA axis; Neurosteroids; Nicotine; Nicotinic receptors; Passive avoidance; PTSD; Smoking; Stress; Transgenic mice

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NICOTINE;

CLINICAL RESEARCH; CORRELATION ANALYSIS; DESENSITIZATION; DISEASE ASSOCIATION; HORMONE DETERMINATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERVENTION STUDY; NEUROSCIENCE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TOBACCO DEPENDENCE;

ANIMALS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NICOTINE; NICOTINIC AGONISTS; PITUITARY-ADRENAL SYSTEM; RESEARCH DESIGN; SMOKING; STRESS DISORDERS, POST-TRAUMATIC; TOBACCO USE DISORDER;

EID: 33748182420     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106060193     Document Type: Review

References (169)

1. Acierno R A, Kilpatrick D G, Resnick H S, Saunders B E, Best C L (1996) Violent assault, posttraumatic stress disorder, and depression. Risk factors for cigarette use among adult women. Behav Modification 20: 363-384
2. Aguilera G (1994) Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15: 321-350
3. Ameli R, Chris I P, Grillon C (2001) Contextual fear-potentiated startle conditioning in humans: Replication and extension. Psychophysiol 38: 383-390
4. American Psychiatric Association (1994) Diagnostic and statistical manual of psychiatric disorders (4th edn). Washington, DC: American Psychiatric Association
5. Anda R F, Williamson D F, Escobedo L G, Mast E E, Giovino G A, Remington P L (1990) Depression and the dynamics of smoking. A national perspective. JAMA 264: 1541-1545
6. Antonijevic I A, Murck H, Bohlhalter S, Frieboes R M, Holsboer F, Steiger A (2000) Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 39: 1474-1481
7. Arnsten A F T, Goldman-Rakic P S (1998) Noise stress impairs prefrontal cortical cognitive function in monkeys: Evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 55: 362-369
8. Assaf A R, Parker D, Lapane K L, McKenney J L, Carleton RA (2002) Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J Women's Health 11: 899-906
9. Baghai T C, Schule C, Zwanzger P, Minov C, Zill P, Ella R, Eser D, Oezer S, Bondy B, Rupprecht R (2002) Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci Lett 325: 299-303
10. Balfour D J K, Khullar A K, Longden A (1975) Effects of nicotine on plasma corticosterone and brain amines in stressed and unstressed rats. Pharmacol Biochem Behav 3: 179-184
11. Barbaccia M L, Roscetti G, Trabucchi M, Purdy R H, Mostallino M C, Concas A, Biggio G (1997) The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol 120: 1582-1588
12. Barbaccia M L, Roscetti G, Trabucchi M, Purdy R H, Mostallino M C, Perra C, Concas A, Biggio G (1996) Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain. Neuropharmacol 35: 1299-1305
13. Baron J A, Comi R J, Cryns V, Brinck-Johnsen T, Mercer N G (1995) The effect of cigarette smoking on adrenal cortical hormones. J Pharm Exp Ther 272: 151-155
14. Baulieu E-E, Robel P (1998) Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci 95: 4089-4091
15. Beckham J C, Kirby A C, Feldman M E, Hertzberg M A, Moore S D, Crawford A L, Davidson J R, Fairbank J A (1997) Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addictive Behav 22: 637-647
16. Beckham J C, Gehrman P R, McClernon F J, Collie C F, Feldman M E (2004) Cigarette smoking, ambulatory cardiovascular monitoring, and mood in Vietnam veterans with and without chronic posttraumatic stress disorder. Addictive Behav 29: 1579-1593
17. Beckham J C, Lytle B L, Vrana S R, Hertzberg M A, Feldman M E, Shipley R H (1996) Smoking withdrawal symptoms in response to a trauma-related stressor among Vietnam combat veterans with posttraumatic stress disorder. J Addictive Behav 21: 93-101
18. Benowitz N L (1983) The use of biological fluid samples in assessing tobacco smoke consumption. NIDA Research Monograph 48: 6-26
19. Benowitz N L, Jacob P III (1994) Metabolism of nicotine to cotinine studied by a dual isotope method. Clin Pharamcol Ther 56: 483-493
20. Benowitz N L, Perez-Stable E J, Herrera B, Jacob P III (2002) Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Nat Cancer Inst 94: 108-115
21. Benowitz N L, Perez-Stable E J, Fong I, Modin G. Herrera B. Jacob P III (1999) Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharm Exp Therapeutics 297: 1196-1203
22. Benwell M E M, Balfour D J K (1982) Effects of chronic nicotine administration on the response and adaptation to stress. Psychopharm 76: 160-162
23. Benyamina M, Leboulenger F, Lirhmann I, Delarue C, Feuilloley M, Vaudry H (1987) Acetylcholine stimulates steroidogenesis in isolated frog adrenal gland through muscarinic receptors: evidence for a desensitization mechanism. J Endocrinology 113: 339-348
24. Biglan A, Gallison C, Ary D, Thompson R (1985) Expired air carbon monoxide and saliva thiocyanate: relationships to self-reports of marijuana and cigarette smoking. Addictive Behav 10: 137-144
25. Blauer K L, Poth M, Rogers W, Bernton E (1991) DHEA antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinol 129: 3174-3179
26. Breslau N, Klein D F (1999) Smoking and panic attacks: an epidemiologic investigation. Arch Gen Psychiatry 56: 1141-1147
27. Breslau N, Davis G C, Schultz L R (2003) Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry 60: 289-294
28. Breslau N, Novak S P, Kessler R C (2004) Psychiatric disorders and stages of smoking. Biol Psychiatry 55: 69-76
29. Breslau N, Davis G C, Peterson E L, Schultz L R (2000) A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection. Biol Psychiatry 48: 902-909
30. Breslau N, Kessler R C, Chilcoat H D, Schultz L R, Davis G C, Andreski P (1998) Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 55: 626-632
31. Breslau N, Kilbey M M, Andreski P (1992) Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 149: 464-469
32. Broocks A, Bandelow B, Koch K, Bartmann U, Kinkelbur J, Schweiger U, Hohagen F, Hajak G (2002) Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder. Neuropsychopharm 27: 270-278
33. Bullock A E, Clark A L, Grady S R, Robinson S F, Slobe B S, Marks M J, Collins A C (1997) Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem 68: 2412-2423
34. Caggiula A R, Donny E C, Epstein L H, Sved A F, Knopf S, Rose C, McAllister C G, Antelman S M, Perkins K A (1998) The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrin 23: 143-159
35. Cam G R, Bassett J R (1984) Effect of prolonged exposure to nicotine and stress on the pituitary-adrenocortical response; the possibility of cross-adaptation. Pharm Biochem Beh 20: 221-226
36. Challis B G, Luan J, Keogh J, Wareham N J, Farooqi I S, O'Rahilly S (2004) Genetic variation in the corticotrophin-releasing factor receptors: identification of single-nucleotide polymorphisms and association studies with obesity in UK Caucasians. Int J Obesity Metab Dis J Int Assoc Study Obesity 28: 442-446,
37. Chambers R A, Krystal J H, Self D W (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50: 71-83
38. Charmandari E, Merke D P, Negro P J, Keil M F, Martinez P E, Haim A, Gold P W, Chrousos G P (2004) Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. J Clin End Metab 89: 2228-2236
39. Coiro V, Vescovi P P (1999) Effect of cigarette smoking on ACTH/cortisol secretion in alcoholic after short- and medium-term abstinence. Alcoholism: Clin Exp Res 23: 1515-1518
40. Compagnone N A, Mellon S H (2000) Neurosteroids: Biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21: 1-56
41. Corder R, Castagne V, Rivet J-M, Mormede P, Gaillard R C (1992) Central and peripheral effects of repeated stress and high NaCl diet on neuropeptide Y. Physiol Behav 52: 205-210
42. Corrigall W A, Coen K M (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharm 99: 473-478
43. Cruess D G, Antoni M H, Kumar M, Ironson G, McCabe P, Fernandez J B, Fletcher M, Schneiderman N (1999) Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinol 24: 537-549
44. del Arbol J L, Munoz J R, Ojeda L, Cascales A L, Irles J R, Miranda M T, Ruiz Requena M E, Aguirre J C (2000) Plasma concentrations of beta-endorphin in smokers who consume different numbers of cigarettes per day. Pharmacol Biochem Behav 67: 25-28
45. Deutch A Y, Roth R H ( 1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 85: 367-402
46. Dickstein G, Shechner C, Nicholson W E, Rosner I, Shen-Orr Z, Adawi F, Lahav M (1991) Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 72: 773-778
47. Faiman C P, de Erausquin G A, Baratti C M (1991) The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms. Behav Neural Biol 56: 183-199
48. First M B, Spitzer R L, Gibbon M, Williams J B (1995a) Structured Clinical Interview for the DSM-IV Axis I Disorders, NonPatient Edition (SCID-I/NP, Version 2.0). Biometrics Research Dept, New York State Psychiatric Institute, New York, NY
49. First M B, Spitzer R L, Gibbon M, Williams J B (1995b) Structured Clinical Interview for the DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Dept, New York State Psychiatric Institute, New York, NY
50. Frederick S L, Reus V l, Ginsberg D, Hall S M, Munoz R F, Ellman G (1998) Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry 43: 525-530
51. Freund R K, Martin B J, Jungschaffer D A, Ullman E A, Collins A C (1988) Genetic differences in plasma corticosterone levels in response to nicotine injection. Pharmacol Biochem Behav 30: 1059-1064
52. Fu Y, Matta S G, Kane V B, Sharp B M (2003) Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study. Neuropharmacology 45: 514-523
53. Garcia Calzado M C, Garcia Rojas J F, Mangas Rojas A, Martinez Izquierdo D, Repetto M, Millan J (1990) Tobacco and arterial pressure (L). The hormonal changes in a model of acute nicotine overload. Anales de Medicina Interna 7: 340-344
54. Garriti P, Alterman A I, Eherman R, Mulvaney F D, O'Brien C P (2002) Detecting smoking following smoking cessation treatment. Drug Alcohol Dependence 65: 191-196
55. George T P, Vessicchio J C, Termine A, Sahady D M, Head C A, Pepper W T, Kosten T R, Wexler B E (2002) Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharm 26: 75-85
56. Goldstein L E, Rasmusson A M, Bunney B S, Roth R H (1996) Role of the amygdala in the coordination of behavioral, neuroendocrine and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 16: 4787-4798
57. Gonzalez-Gay M A, Hajeer A H, Garcia-Porrua C, Dababneh A, Amoli M M, Botana M A, Thomson W, Llorca J, Ollier W E (2003) Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from northwest Spain. J Rheumatology 30: 913-917
58. Goodyer I M, Herbert J, Altham P M E (1998) Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med 28: 265-273
59. Gould T J, Wehner J M (1999) Nicotine enhancement of contextual fear conditioning. Behav Brain Res 102: 31-39
60. Gould T J, Collins A C, Wehner J M (2001) Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. Nicotine Tob Res 3: 17-24
61. Gries J M (1998) Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems. J Pharmacol Exp Ther 285: 457-463
62. Grillon C, Morgan CA III (1999) Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Ab Psych 108: 134-142
63. Gritz E R, Carr C R, Marcus A C (1991) The tobacco withdrawal syndrome in unaided quitters. Br J Addiction 86: 57-69
64. Grota L J, Bienen T, Felten B D L (1997) Corticosterone responses of adult Lewis and Fischer rats. J Neuroimmunol 74: 95-101
65. Grundemann D, Schechinger B, Rappold G A, Schomig E (1998) Molecular identification of the cortisone-sensitive extraneuronal catecholamine transporter. Nature Neurosci 1: 349-351
66. Haley N J, Axelrad C M, Tilton K A (1983) Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. American Journal of Public Health. 73: 1204-1207
67. Haley N J, Hoffman D (1985) Analysis for nicotine and cotinine in hair to determine cigarette smoker status. Clin Chem 31: 1598-1600
68. Hatsukami D (1994) Effects of nicotine gum on withdrawal symptoms in females vs. males. Paper presented at the American Psychological Association, Psychosocial and Behavioral Factors in Women's Health: Creating an Agenda for the 21st Century, Washington, DC
69. Haufroid V, Lison D (1998) Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 71: 162-168
70. Heatherton T F, Kozlowski L T, Frecker R C, Fagerstrom K O (1991) The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addiction 86: 1119-1127
71. Heilig M (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Reg Peptides 59: 201-205
72. Heilig M, Soderpalm B, Engel J, Widerlov E (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacol 98: 524-529
73. Heim C, Newport D J, Heit S, Graham Y P, Wilcox M, Bonsall R, Miller A H, Nemeroff C B (2000) Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284: 592-597
74. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz O M, Linnoila M (1999) Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 89: 97-106
75. Hernandez-Avila C A, Wand G, Luo X, Gelernter J, Kranzler H R (2003) Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genetics 118B: 60-65
76. Hoge C W, Castro C A, Messer S C, McGurk D, Cotting D I, Koffman R L (2004) Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New Engl J Med 351: 13-22
77. Hughes J R, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294
78. Isensee B, Wittchen H U, Stein M B, Hofler M, Lieb R (2003) Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry 60: 692-700
79. Jacobs A R, Edelheit P B, Coleman A E, Herzog A G (1999) Late-onset congenital adrenal hyperplasia: a treatable cause of anxiety. Biol Psychiatry 46: 856-859
80. Jatlow P, McKee S, O'Malley S S (2003) Correction of urine cotinine concentrations for creatine excretion. Clin Chem 49: 1932-1934
81. Johnson D H, Svensson A I, Engel J A, Soderpalm B (1995) Induction but not expression of behavioral sensitization to nicotine in the rat is dependent on glucocorticoids. Eur J Pharmacol 276: 155-164
82. Johnson J G, Cohen P, Pine D S, Klein D F, Kasen S, Brook J S (2000) Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 284: 2348-2351
83. Josselyn S A, Beninger R J (1993) Neuropeptide Y: Intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol Biochem Behav 46: 543-552
84. Kallio J, Pesonen U, Kaipio K, Karvoven M, Jaakkola U, Heinonen O, Usuitupa M I J, Koulu M (2001) Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J 15: 1242-1244
85. Ke L, Lukas R J (1996) Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. J Neurochem 67: 1100-1112
86. King, S, Picciotto M R (2003) Effects of chronic nicotine exposure on emotional learning in mice. Society for Neuroscience Abstracts Vol 29
87. King S L, Marks M J, Grady S R, Caldarone B J, Koren A O, Mukhin A G, Collins A C, Picciotto M R (2003) Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. J Neurosci 23: 3837-3843
88. Kirschbaum C, Scherer G, Strasburger C J (1994) Pituitary and adrenal hormone responses to pharmacological, physical, and psychological stimulation in habitual smokers and nonsmokers. Clin Investig 72: 804-810
89. Koenen K C, Hitsman B, Lyons M J, Niaura R, McCaffery J, Goldberg J, Eisen S A, True W, Tsuang M (2005) A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Arch Gen Psychiatry 62: 1258-1265
90. Krishnan-Sarin S, Rosen M I, O'Malley S (1999) Naloxine challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Arch Gen Psychiatry 56: 663-668
91. Krueger R J, Lin C M, Fung Y K (1991) Effect of chronic administration of nicotine or cocaine on steroidogenesis in rat adrenocortical cells. J Pharm Pharmacol 43: 200-203
92. Kyllo J H, Collins M M, Vetter K L, Cuttler L, Rosenfield R L, Donohoue P A (1996) Linkage of congenital isolated adrenocorticotropic hormone deficiency to the corticotropin releasing hormone locus using simple sequence repeat polymorphisms. Am J Med Genetics 62: 262-267
93. Lamba V, Yasuda K, Lamba J K, Assem M, Davila J, Strom S, Schutetz E G (2004) PXR (NR112) splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Tox App Pharmacol 199: 251-265
94. Lambe E K, Picciotto M R, Aghajanian G K (2003) Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharm 28: 216-225
95. Leonard S, Adler L E, Benhammou K, Berger R, Breese C R, Drebing C, Gault J, Lee M J, Logel J, Olincy A, Ross R G, Stevens K, Sullivan B, Vianzon R, Virnich D E, Waldo M, Walton K, Freedman R (2001) Smoking and mental illness. Pharm Biochem Behav 70: 561-570
96. Lipschitz D S, Rasmusson A M, Yehuda R, Wang S, Anyan W, Gueoguieva R, Grilo C, Fehon D C, Southwick S M (2003) Salivary cortisol responses to dexamethasone in adolescents with posttraumatic stress disorder. J Am Acad Child Adol Psychiatry 42: 1310-1317
97. Mantsch J R, Saphier D, Goeders N E (1998) Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone. J Pharm Exp Ther 287: 72-80
98. Marti O, Gavalda A, Gomez F, Armario A (1994) Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to a novel acute stressor. Neuroendocrinol 60: 1-7
99. McCabe R E, Chudzik S M, Antony M M, Young L, Swinson R P, Zolvensky M J (2004) Smoking behaviors across anxiety disorders. J Anxiety Dis 18: 7-18
100. Matta S G, Singh J, Sharp B M (1990) Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors. Endocrinology 127: 1646-1655
101. Matta S G, Valentine J D, Sharp B M (1997a) Nicolinic activation of CRH neurons in extrahypothalamic regions of the rat brain. Endocrine J 7: 245-253
102. Matta S G, Valentine J D, Sharp B M (1997b) Nicotine activates NPY and catecholaminergic neurons in brainstem regions involved in ACTH secretion. Brain Res 759: 259-269
103. Matta S G, Fu Y, Valentine J D, Sharp B M (1998) Response of the hypothalamo-piluitary-adrenal axis to nicotine. Psychoneuroendocrin 23: 103-113
104. Michael A, Jenaway A, Paykel E S, Herbert J (2000) Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry 48: 989-995
105. Morfin R, Starka L (2001) Neurosteroid 7-hydroxylation products in the brain. Int Rev Neurobiol 46: 79-95
106. Morgan C A III, Rasmusson A M, Wang S, Hoyt G, Hauger R, Hazlett G (2002) Neuroeptide Y and subjective distress in humans exposed to acute stress: Replication and extension of previous report. Biol Psychiatry 52: 136-142
107. Morgan C A III, Southwick S, Hazlett G, Rasmusson A, Hoyt G, Zimolo Z, Charney D (2004) Relationships among plasma DHEA(S), cortisol, symptoms of dissociation and objective performance in humans exposed to acute stress. Arch Gen Psychiatry 61: 819-822
108. Morgan C A, Wang S, Southwick S M, Rasmusson A, Hazlett G, Hauger R L, Charney D S (2000) Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry 47: 902-909
109. Morrow B A, Elsworth J D, Rasmusson A M, Roth R H (1999) The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neurosci 92: 553-564
110. Mulchahey J J, Ekhator N N, Zhang H, Kasckow J W, Baker D G, Geracioti T D Jr (2001) Cerebrospinal fluid and plasma testosterone levels in post-traumatic stress disorder and tobacco dependence. Psychoneuroendocrin 26: 273-285
111. Nordberg A, Bergh C (1985) Effect of nicotine on passive avoidance behaviour and motoric activity in mice. Acta Pharm Toxicol 56: 337-341
112. Oswald L M, McCaul M, Choi L, Yang X, Wand G S (2004) Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report. Biol Psychiatry 55: 102-105
113. Pauly J R, Collins A C (1993) An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. Neuroendocrin 57: 262-271
114. Perez-Stable E J, Benowitz N L, Marin G (1995) Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med 24: 171-179
115. Piazza P V, Maccari S, Deminiere J M, Le Moal M, Mormede P, Simon H (1991) Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci 88: 2088-2102
116. Picciotto M R (2003) Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24: 493-499
117. Picciotto M R, Zoli M, Léna C, Bessis A, Lallemand Y, Le Novère N, Vincent P, Merlo Pich E, Brulet P, Changeux J-P (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374: 65-67
118. Pickworth W B, Fant R V (1998) Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrin 23: 131-141
119. Pinna G, Costa E, Guidotti A (2005) Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. PNAS 102: 2135-2140
120. Pokorski T L, Chen W W, Bertholf R L (1994) Use of urine cotinine to validate smoking self-reports in U.S. navy recruits. Addictive Behav 19: 451-454
121. Pomerleau C S, Tate J C, Lumley M A, Pomerleau O F (1994) Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms. J Substance Abuse 6: 433-440
122. Pomerleau O F, Pomerleau C S (1989) Cortisol response to a psychological stressor and/or nicotine. Pharmacol Biochem Behav 36: 211-213
123. Pomerleau O F, Fertig J B, Shanahan S O (1983) Nicotine dependence in cigarette smoking: an empirically-based, multivariate model. Pharmacol Biochem Behav 19: 291-299
124. Porcu P, Sogliano C, Cinus M, Purdy R H, Biggio G, Concas A (2003) Nicotine-induced changes in cerebrocortical neuroactive steroids and plasma corticosterone concentrations in the rat. Pharmacol Biochem Behav 74: 683-690
125. Purdy R H, Morrow A L, Moore P H, Paul S M (1991) Stress-induced elevations of GABA type A receptor-active steroids in the rat brain. Proc Natl Acad Sci 88: 4553-4557
126. Rasmusson A, Pinna G, Weisman D, Gottschalk C, Charney D, Krystal J, Guidotti A (2005) Decreases in CSF allopregnanolone levels in women with PTSD correlate negatively with reexperiencing symptoms. Abst. Society of Biological Psychiatry Annual Meeting, Atlanta, Georgia, 19-21 May
127. Rasmusson A M, Vythilingam M, Morgan C A III (2003) The neuroendocrinology of PTSD - new directions. In Shalev A (ed.), CNS Spectrums, The International Journal of Neuropsychiatric Med 8: 651-667
128. Rasmusson A M, Hauger R L, Morgan C A III, Bremner J D, Charney D S, Southwick S M (2000) Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) in combat-related posttraumatic stress disorder. Biol Psychiatry 47: 526-539
129. Rasmusson A M, Lipschitz D S, Wang S, Hu S, Vojvoda D, Bremner J D, Southwick S M, Charney D S (2001) Increased pituitary and adrenal reactivity in premenopausal women with PTSD. Biol Psychiatry 50: 965-977
130. Rasmusson A M, Vasek J, Lipschitz D, Mustone M E, Vojvoda D, Shi Q, Gudmundsen G, Morgan C A III, Wolfe J, Charney D S (2004) An increased capacity for adrenal DHEA release is associated negatively with avoidance symptoms and negative mood in women with PTSD. Neuropsychopharm 29: 1546-1557
131. Rhodes M E, O'Toole S M, Czambel R K, Rubin R T (2001) Male-female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation. Brain Res Bull 54: 681-688
132. 1 (σ1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharm 175: 154-162
133. Rose J E, Levin E D, Benowitz N (1993) Saliva nicotine as an index of plasma levels in nicotine skin patch uses. Ther Drug Monit 15: 431-435
134. Rubin R P, Warner W (1975) Nicotine-induced stimulation of steroidogenesis in adrenocortical cells of the cat. Br J Pharm 53: 357-362
135. Rudehill A, Franco-Cereceda A, Hemsen A, Stensdotter M, Pernow J, Lundberg J M (1989) Cigarette smoke-induced elevation of plasma neuropeptide Y levels in man. Clinical Physiology 9: 243-248
136. Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrin 28: 139-168
137. Sartori M P, Sellini M, Baccarini S, Fabiani F (1993) Cigarette smoking and hormonal changes in the course of the menstrual cycle. Clinica Terapeutica 143: 15-18
138. Schumann A, Hapke U, Meyer C, Rumpf H J, John U (2004) Prevalence, characteristics, associated mental disorders and predictors of DSM-IV nicotine dependence. Eur Addiction Res 10: 29-34
139. Seeker-Walker R H, Vacek P M, Flynn B S, Mead P B (1997) Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addictive Behav 22: 671-684
140. Sellini M, Baccarini S, Dimitriadis E, Sartori M P, Letizia C (1989a) Effect of smoking on the hypophyseo-adrenal axis. Medicina 9: 194-196
141. Sellini M, Sartori M P, Baccarini S, Bassi R, Dimitriadis E (1989b) ACTH and cortisol after cigarette smoke exposure during the dexamethasone suppression test in smokers and non-smokers. Biologia Sperimentale 65: 377-380
142. Semba J, Wakuta M, Maeda J, Suhara T (2004) Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation. Psychoneuroendocrin 29: 215-226
143. Sepkovic D W, Haley N J (1985) Biomedical applications of cotinine quantification in smoking related research. Am J Public Health 75: 663-665
144. Shaffer H J, Eber G B, Hall M N, Vander Bilt J (2000) Smoking behavior among casino employees: self-report validation using plasma cotinine. Addictive Behavior 25: 693-704
145. Shalev A, Bleich A, Ursano R J (1990) Posttraumatic stress disorder: somatic comorbidity and effort tolerance. Psychosomatics 31: 197-203
146. Sharp B M, Beyer H S (1986) Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J Pharm Exp Ther 238: 486-491
147. Shiffman S (1982) Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 50: 71-86
148. Slawik M, Reisch N, Zwermann O, Maser-Gluth C, Stahl M, Klink A, Reincke M, Beuschlein F (2004) Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH. J Clin Endo Metab 89: 3131-3137
149. Smoller J W, Rosenbaum J F, Biederman J, Kennedy J, Dai D, Racette S R, Laird N M, Kagan J, Snidman N, Hirshfeld-Becker D, Tsuang M T, Sklar P B, Slaugenhaupt S A (2003) Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry 54: 1376-1381
150. Sobell L C, Sobell M B (1992) Timeline followback: a technique for assessing self-reported ethanol consumption. In Allen J, Litten R Z (eds) Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Humana Press, Inc. Totowa, NJ, 41-72
151. Sondergaard H P, Hansson L-O, Theorell T (2002) Elevated blood levels dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden. Psychother Psychosom 71: 298-303
152. Southwick S M, Rasmusson A M, Barron J, Arnsten A (in press) Neurobiological and neurocognitive alterations in PTSD: a focus on norepinephrine, serotonin, and the HPA axis. In Vasterling J, Brewin C (eds) Neuropsychology of PTSD. Guilford Publications, New York, NY
153. Southwick S M, Bremner J D, Rasmusson A, Morgan C A III, Arnsten A, Charney S (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46: 1192-1204
154. A-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol Med 30: 1227-1231
155. SRNT subcommittee on Biochemical Verification (2002) Biochemical verification of tobacco and cessation. Nicotine Tob Res 4: 149-159
156. Svikis D S, Hatsukami D K, Hughes J R, Carroll K M, Pickens R W (1986) Sex differences in tobacco withdrawal syndrome. Addictive Behav 11: 459-462
157. Tiffany S T, Drobes D J (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86: 1467-1476
158. Tsuda A, Steptoe A, West R, Fieldman G, Kirschbaum C (1996) Cigarette smoking and psychophysiological stress responsiveness effects of recent smoking and temporary abstinence. Psychopharmacol 126: 226-233
159. VanRooyen M, Leaning J (2005) After the tsunami - facing the public health challenges. New England J Med 352: 435-438
160. Wagenknecht L E, Burke G L, Perkins L L, Haley N J, Friedman G D (1992) Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levels. Am J Public Health 82: 33-36
161. Wald N J, Idle M, Boreham J, Bailey A (1981) Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax 36: 366-369
162. Wang H, Napoli K L, Strobel H W (2000) Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol Cell Biochem 213: 127-135
163. Witchel S, Lee P, Suda-Hartman S, Trucco M, Hoffman E (1997) Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endo Metab 82: 2097-2101
164. Wust S, Van Rossum E F, Federenko I S, Koper J W, Kumsta R, Hellhammer D H (2004) Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endo Metab 89: 565-573
165. Yaffe K, Ettinger B, Pressman A, Seeley D, Whooley M, Schaefer C, Cummings S (1998) Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study. Biol Psychiatry 43: 694-700
166. Yehuda R (2002) Current status of cortisol findings in post-traumatic stress disorder. Psychiatric Clin N Amer 25: 341-368
167. Young A H, Gallagher P, Porter R J (2002) Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry 159: 1237-1239
168. Young E A, Breslau N (2004a) Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 61: 394-401
169. Young E A, Breslau N (2004b) Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol Psychiatry 56: 205-209